The management and outcome of women with post-hydatidiform mole ‘low-risk’ gestational trophoblastic neoplasia, but hCG levels in excess of 100 000 IU l−1-Reference-Cited by-同舟云学术

The management and outcome of women with post-hydatidiform mole ‘low-risk’ gestational trophoblastic neoplasia, but hCG levels in excess of 100 000 IU l−1

Published:2010-02-16 Issue:5 Volume:102 Page:810-814
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

McGrath S,Short D,Harvey R,Schmid P,Savage P M,Seckl M J

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6605529.pdf

Reference24 articles.

1. Bagshawe KD (1976) Risk and prognostic factors in trophoblastic neoplasia. Cancer 38: 1373–1385

2. Bagshawe KD, Dent J, Newlands ES, Begent RG, Rustin GJ (1989) The role of low-dose methotrexate and folinic acid in gestational trophoblastic tumours (GTT). Br J Obstet Gynaecol 96: 795–802

3. Berkowitz RS, Goldstein DP, Bernstein MR (1982) Methotrexate with citrovorum factor rescue as primary therapy for gestational trophoblastic disease. Cancer 50: 2024–2027

4. Bolis G, Colombo N, Epis A, Mangili G, Vassena L, Vergadoro F, Belloni C (1987) Methotrexate with citrovorum factor in low-risk gestational trophoblastic tumor. Tumori 73: 309–313

5. Bolis G, Bonazzi C, Landoni F, Mangili G, Vergadoro F, Zanaboni F, Mangioni C (1988) EMA/CO regimen in high-risk gestational trophoblastic tumor (GTT). Gynecol Oncol 31: 439–444

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Presenting Features and Outcomes of Gestational Trophoblastic Neoplasia: A Case Series from a Single Institution;Indian Journal of Gynecologic Oncology;2024-07-30

2. Risk factors for methotrexate resistance in low-risk gestational trophoblastic neoplasia patients (FIGO score 0-4);American Journal of Cancer Research;2024

3. Efficacy analysis of single-agent carboplatin AUC4 2-weekly as second-line therapy for methotrexate-resistant (MTX-R) low risk gestational trophoblastic neoplasia (GTN);Gynecologic Oncology;2023-08

4. PREDICT‐ GTN 1: Can we improve the FIGO scoring system in gestational trophoblastic neoplasia?;International Journal of Cancer;2022-12-03

5. Prognostic Factors Associated with hCG Remission and Chemotherapy Resistance in Patients with High-Risk Gestational Trophoblastic Neoplasia;Indian Journal of Gynecologic Oncology;2022-10-30